Ovation Science Inc. (CSE:OVAT)
Canada · Delayed Price · Currency is CAD 0.0300
+0.0100 (50.00%)
Aug 1, 2026, 4:04 AM EST
Ovation Science Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.06 | 0.07 | 0.11 | 0.06 | 0.14 | 0.22 | |
Revenue Growth | -11.38% | -40.04% | 82.80% | -55.17% | -38.58% | -70.01% |
Cost of Revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0 | 0.88 |
Gross Profit | 0.03 | 0.04 | 0.09 | 0.04 | 0.13 | -0.66 |
Selling, General & Admin | 0.59 | 0.57 | 0.55 | 0.7 | 0.81 | 0.78 |
Research & Development | - | - | 0.01 | 0.01 | 0.07 | 0.08 |
Operating Expenses | 0.66 | 0.64 | 0.56 | 0.81 | 0.88 | 0.87 |
Operating Income | -0.63 | -0.6 | -0.48 | -0.77 | -0.75 | -1.52 |
Interest Expense | -0.04 | -0.05 | -0.05 | -0.03 | -0 | - |
Interest & Investment Income | - | - | - | - | 0 | 0 |
Currency Exchange Gain (Loss) | - | - | -0 | 0 | -0 | -0 |
Other Non Operating Income (Expenses) | 0.01 | 0.02 | 0.07 | -0.03 | -0.04 | -0.13 |
EBT Excluding Unusual Items | -0.66 | -0.63 | -0.46 | -0.83 | -0.79 | -1.65 |
Asset Writedown | - | - | - | - | - | -0.74 |
Other Unusual Items | - | - | - | 0.02 | - | - |
Pretax Income | -0.66 | -0.63 | -0.46 | -0.81 | -0.79 | -2.39 |
Net Income | -0.66 | -0.63 | -0.46 | -0.81 | -0.79 | -2.39 |
Net Income to Common | -0.66 | -0.63 | -0.46 | -0.81 | -0.79 | -2.39 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 37 | 36 | 35 | 30 | 29 | 29 |
Shares Outstanding (Diluted) | 37 | 36 | 35 | 30 | 29 | 29 |
Shares Change | -1.20% | 1.77% | 15.37% | 3.22% | - | 10.15% |
EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.03 | -0.03 | -0.08 |
EPS (Diluted) | -0.02 | -0.02 | -0.01 | -0.03 | -0.03 | -0.08 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.14 | -0.08 | -0.18 | -0.34 | -0.67 | -0.89 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 |
Gross Margin | 51.70% | 58.63% | 75.71% | 69.86% | 97.07% | -292.67% |
Operating Margin | -1102.10% | -881.14% | -423.12% | -1238.82% | -539.55% | -677.71% |
Profit Margin | -1146.42% | -929.86% | -402.95% | -1312.93% | -574.76% | -1064.14% |
Free Cash Flow Margin | -240.87% | -112.59% | -157.95% | -542.55% | -485.55% | -393.76% |
EBITDA | - | -0.6 | -0.48 | -0.76 | -0.74 | -1.52 |
D&A For EBITDA | - | 0 | 0 | 0 | 0.01 | 0.01 |
EBIT | -0.63 | -0.6 | -0.48 | -0.77 | -0.75 | -1.52 |
Revenue as Reported | 0.06 | 0.07 | 0.11 | 0.06 | 0.14 | 0.22 |
Advertising Expenses | - | 0 | 0 | 0.01 | 0.02 | 0.03 |